Literature DB >> 35307409

Mechanisms underlying melanoma invasion as a consequence of MLK3 loss.

Henriette U Balinda1, Alanna Sedgwick1, Crislyn D'Souza-Schorey2.   

Abstract

Invasive melanoma is an aggressive form of skin cancer with high incidence of mortality. The process of tumor invasion is a crucial primary step in the metastatic cascade, yet the mechanisms involved are still under investigation. Here we document a critical role for MLK3 (MAP3K11) in the regulation of melanoma cell invasion. We report the unexpected finding that cellular loss of MLK3 in melanoma cells promotes cell invasion. Cellular depletion of MLK3 expression results in the hyperactivation of ERK, which is linked to the formation of a BRAF/Hsp90/Cdc37 protein complex. ERK hyperactivation leads to enhanced phosphorylation and inactivation of GSK3β and the stabilization of c-Jun and JNK activity. Blocking of ERK and JNK signaling as well as Hsp90 activity downstream of MLK3-silencing significantly reduces melanoma invasion. Furthermore, ERK activation in the aforementioned context is coupled to MT1-MMP transcription as well as the TOM1L1-dependent localization of the membrane protease to invadopodia at the invasive front. These studies provide critical insight into the mechanisms that couple MLK3 loss with BRAF hyperactivation and its consequence on melanoma invasion.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MLK3; Melanoma; Mitogen activated protein kinase signaling; Signal transduction; Tumor invasion

Mesh:

Substances:

Year:  2022        PMID: 35307409      PMCID: PMC9086996          DOI: 10.1016/j.yexcr.2022.113106

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   4.145


  42 in total

1.  Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family.

Authors:  A C Maroney; J P Finn; T J Connors; J T Durkin; T Angeles; G Gessner; Z Xu; S L Meyer; M J Savage; L A Greene; R W Scott; J L Vaught
Journal:  J Biol Chem       Date:  2001-04-26       Impact factor: 5.157

2.  MLK3 regulates paxillin phosphorylation in chemokine-mediated breast cancer cell migration and invasion to drive metastasis.

Authors:  Jian Chen; Kathleen A Gallo
Journal:  Cancer Res       Date:  2012-06-13       Impact factor: 12.701

3.  ARF6-regulated endocytosis of growth factor receptors links cadherin-based adhesion to canonical Wnt signaling in epithelia.

Authors:  Oscar Pellon-Cardenas; James Clancy; Henriette Uwimpuhwe; Crislyn D'Souza-Schorey
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

Review 4.  Optimal management of metastatic melanoma: current strategies and future directions.

Authors:  Marta Batus; Salman Waheed; Carl Ruby; Lindsay Petersen; Steven D Bines; Howard L Kaufman
Journal:  Am J Clin Dermatol       Date:  2013-06       Impact factor: 7.403

5.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

6.  Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors.

Authors:  Junko Ueda; Masahiro Kajita; Naoko Suenaga; Katsuyuki Fujii; Motoharu Seiki
Journal:  Oncogene       Date:  2003-11-27       Impact factor: 9.867

7.  TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion.

Authors:  Clément Chevalier; Guillaume Collin; Simon Descamps; Heiani Touaitahuata; Valérie Simon; Nicolas Reymond; Laurent Fernandez; Pierre-Emmanuel Milhiet; Virginie Georget; Serge Urbach; Laurence Lasorsa; Béatrice Orsetti; Florence Boissière-Michot; Evelyne Lopez-Crapez; Charles Theillet; Serge Roche; Christine Benistant
Journal:  Nat Commun       Date:  2016-02-22       Impact factor: 14.919

8.  Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited.

Authors:  Farideh Sabeh; Ryoko Shimizu-Hirota; Stephen J Weiss
Journal:  J Cell Biol       Date:  2009-03-30       Impact factor: 10.539

9.  MLK4β functions as a negative regulator of MAPK signaling and cell invasion.

Authors:  W F Abi Saab; M S Brown; D N Chadee
Journal:  Oncogenesis       Date:  2012-03-26       Impact factor: 7.485

Review 10.  MLK3 Signaling in Cancer Invasion.

Authors:  Chotirat Rattanasinchai; Kathleen A Gallo
Journal:  Cancers (Basel)       Date:  2016-05-19       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.